WallStSmart
TXG

10X Genomics Inc

NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES

$22.05
+9.16% today

Updated 2026-04-30

Market cap
$2.61B
P/E ratio
P/S ratio
4.05x
EPS (TTM)
$-0.35
Dividend yield
52W range
$8 – $26
Volume
2.4M

WallStSmart proprietary scores

27
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C
6.5
Quality
B
2.0
Profitability
F
6.7
Valuation
B
5/9
Piotroski F-Score
Moderate
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$24.00
+8.84%
12-Month target
Intrinsic (DCF)
$69.50
Margin of safety
+72.45%
1 Strong Buy5 Buy10 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $39.00M — positive
+ 72.45% below intrinsic value
Risks
- Thin margins at -6.77%

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$516.41M$618.73M$610.78M$642.82M$642.82M
Net income$-166.00M$-255.10M$-182.63M$-43.54M$-16.25M
EPS$-0.35
Free cash flow$-165.27M$-64.72M$-5.73M$130.12M$39.00M
Profit margin-32.15%-41.23%-29.90%-6.77%-6.77%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
TXG$2.61B274.72.06.76.5+72.45%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

10X Genomics Inc trades at $22.05. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $642.82M. with profit margins at -6.77%. Our DCF model estimates intrinsic value at $69.50.

Frequently asked questions

What is 10X Genomics Inc's stock price?
10X Genomics Inc (TXG) trades at $22.05.
Is 10X Genomics Inc overvalued?
Smart Value Score 27/100 (Grade F, Strong Sell). DCF value $69.50.
What is the price target of 10X Genomics Inc (TXG)?
The analyst target price is $24.00, representing +8.8% upside from the current price of $22.05.
What is the intrinsic value of 10X Genomics Inc (TXG)?
Based on our DCF model, intrinsic value is $69.50, a +72.5% margin of safety versus $22.05.
What is 10X Genomics Inc's revenue?
TTM revenue is $642.82M.
Piotroski F-Score?
5/9 — moderate financial health.

Company info

SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio4.05x
ROE-5.78%
Beta2.17
50D MA$21.21
200D MA$16.84
Shares out0.12B
Float0.12B
Short ratio
Avg volume2.4M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years